Survivors of blood or marrow transplant (BMT) face a significant risk of developing cutaneous malignant neoplasms, including ...

The US Food and Drug Administration (FDA) has approved Unloxcyt (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are ...

Knowledge of the association between HPV and oropharyngeal squamous cell carcinoma is poor and did not improve from 2018 to 2020.

Acanthomatous ameloblastoma: This is usually just an oral tumor in dogs, but it can cause swelling of the jaw. It will almost ...

Doctors found that tying an underskirt too tightly can lead to the development of Marjolin ulcer, also known as squamous cell carcinoma, which is a rare and aggressive type of skin cancer ...

Unloxcyt was approved by the FDA as a new treatment for patients with locally advanced or metastatic cutaneous squamous cell ...

The chef was able to ring the victory bell to mark the end of her cancer treatment and is getting her tastebuds back. Here's what to know about tongue cancer.

The National Health Insurance (NHI) cannot provide the best care for people with lung cancer despite government goals to ...

The recommended commercial dosage of UNLOXCYT is 1,200 mg administered as an intravenous infusion over 60 minutes every three weeks. Cutaneous squamous cell carcinoma (cSCC) is the second most common ...

BioNTech SE said on Friday it has been informed by its partner OncoC4 that the U.S. Food and Drug Administration has lifted ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

ESPN analyst Randy Moss, who retired from the NFL in 2012 after 14 seasons, revealed that he is a “cancer survivor” and will ...